These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 24732188)

  • 1. Therapeutic options for functional dyspepsia.
    Vanheel H; Tack J
    Dig Dis; 2014; 32(3):230-4. PubMed ID: 24732188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional Dyspepsia].
    Oh JH; Kwon JG
    Korean J Gastroenterol; 2019 Feb; 73(2):77-83. PubMed ID: 30845383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria.
    Xiao YL; Peng S; Tao J; Wang AJ; Lin JK; Hu PJ; Chen MH
    Am J Gastroenterol; 2010 Dec; 105(12):2626-31. PubMed ID: 20823838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs under development for the treatment of functional dyspepsia and related disorders.
    Tack J; Masuy I; Van Den Houte K; Wauters L; Schol J; Vanuytsel T; Vandenberghe A; Carbone F
    Expert Opin Investig Drugs; 2019 Oct; 28(10):871-889. PubMed ID: 31566013
    [No Abstract]   [Full Text] [Related]  

  • 5. Rome III functional dyspepsia subdivision in PDS and EPS: recognizing postprandial symptoms reduces overlap.
    Carbone F; Holvoet L; Tack J
    Neurogastroenterol Motil; 2015 Aug; 27(8):1069-74. PubMed ID: 26220647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of drug therapy for functional dyspepsia.
    Chen SL
    J Dig Dis; 2013 Dec; 14(12):623-5. PubMed ID: 23957752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and emerging therapeutic options for the management of functional dyspepsia.
    Vandenberghe A; Schol J; Van den Houte K; Masuy I; Carbone F; Tack J
    Expert Opin Pharmacother; 2020 Feb; 21(3):365-376. PubMed ID: 31899982
    [No Abstract]   [Full Text] [Related]  

  • 8. [Guidelines for the treatment of functional dyspepsia].
    Jee SR; Jung HK; Min BH; Choi KD; Rhee PL; Kang YW; Lee SI;
    Korean J Gastroenterol; 2011 Feb; 57(2):67-81. PubMed ID: 21350319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional dyspepsia: new insights into pathogenesis and therapy.
    Talley NJ
    Korean J Intern Med; 2016 May; 31(3):444-56. PubMed ID: 27048251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current management strategies and emerging treatments for functional dyspepsia.
    Camilleri M; Stanghellini V
    Nat Rev Gastroenterol Hepatol; 2013 Mar; 10(3):187-94. PubMed ID: 23381190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acotiamide, a novel gastroprokinetic for the treatment of patients with functional dyspepsia: postprandial distress syndrome.
    Altan E; Masaoka T; Farré R; Tack J
    Expert Rev Gastroenterol Hepatol; 2012 Sep; 6(5):533-44. PubMed ID: 23061703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rome III criteria cannot distinguish patients with chronic gastritis from those functional dyspepsia patients.
    Wei Z; Ying L; Wen G; Mengnan Z; Yali Z
    Helicobacter; 2014 Apr; 19(2):124-8. PubMed ID: 24617669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification.
    Suzuki H; Nishizawa T; Hibi T
    J Gastroenterol; 2006 Jun; 41(6):513-23. PubMed ID: 16868798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: current treatment options and management of functional dyspepsia.
    Lacy BE; Talley NJ; Locke GR; Bouras EP; DiBaise JK; El-Serag HB; Abraham BP; Howden CW; Moayyedi P; Prather C
    Aliment Pharmacol Ther; 2012 Jul; 36(1):3-15. PubMed ID: 22591037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging drugs for functional dyspepsia.
    Zala AV; Walker MM; Talley NJ
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):221-33. PubMed ID: 25645940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia.
    Wauters L; Dickman R; Drug V; Mulak A; Serra J; Enck P; Tack J; ; Accarino A; Barbara G; Bor S; Coffin B; Corsetti M; De Schepper H; Dumitrascu D; Farmer A; Gourcerol G; Hauser G; Hausken T; Karamanolis G; Keszthelyi D; Malagelada C; Milosavljevic T; Muris J; O'Morain C; Papathanasopoulos A; Pohl D; Rumyantseva D; Sarnelli G; Savarino E; Schol J; Sheptulin A; Smet A; Stengel A; Storonova O; Storr M; Törnblom H; Vanuytsel T; Velosa M; Waluga M; Zarate N; Zerbib F
    United European Gastroenterol J; 2021 Apr; 9(3):307-331. PubMed ID: 33939891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptom overlap between postprandial distress and epigastric pain syndromes of the Rome III dyspepsia classification.
    Vakil N; Halling K; Ohlsson L; Wernersson B
    Am J Gastroenterol; 2013 May; 108(5):767-74. PubMed ID: 23567354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.
    Hojo M; Nagahara A; Asaoka D; Takeda T; Izumi K; Matsumoto K; Ueyama H; Shimada Y; Matsumoto K; Nojiri S; Watanabe S
    Digestion; 2017; 96(1):5-12. PubMed ID: 28605740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategies for the treatment of dyspepsia.
    Kandulski A; Venerito M; Malfertheiner P
    Expert Opin Pharmacother; 2010 Oct; 11(15):2517-25. PubMed ID: 20726822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting and postprandial gastric sensorimotor activity in functional dyspepsia: postprandial distress vs. epigastric pain syndrome.
    Di Stefano M; Miceli E; Tana P; Mengoli C; Bergonzi M; Pagani E; Corazza GR
    Am J Gastroenterol; 2014 Oct; 109(10):1631-9. PubMed ID: 25199472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.